-We present here a cross-sectional study analyzing the IgG1 and IgG2 immune responses to natural canine Leishmania (L.) infantum chagasi-infection and their relationships with delayed-type hypersensitivity (DTH) in 50 mongrel dogs with previous positive serodiagnoses (IFAT-IgG) (56% with subclinical status [= apparently healthy] and 44% clinically sick), living in endemic areas for visceral leishmaniasis in the Brazilian Amazon. IgG1 and IgG2 responses were measured using commercial polyclonal antibodies in ELISA, while DTH was elicited by intradermal skin test using cultured promastigotes L. (L.) i. chagasi-antigen. Data analyses used Chi-square and Pearson's r coefficient (95% confidence interval). Regarding DTH and the clinical statuses of dogs, it was noted that 100% of the animals showing positive DTH (n = 8) were from the subclinical group, while 100% showing negative DTH were from the clinically sick group; higher IgG2 than IgG1 responses were observed in both clinical groups. However, when this comparison was made between the subclinical and sick groups, higher IgG1 responses were noted in the dogs from the sick rather than the subclinical group, while no differences were noted between the IgG2 responses in the dogs from both clinical groups. Additionally, we found lower IgG1 responses in dogs from the subclinical group showing positive DTH than in the dogs from the subclinical or sick groups with negative DTH; no differences were found between the IgG2 responses of these two clinical groups. These findings suggest that the IgG1, but not the IgG2, response is associated with susceptibility to canine visceral leishmaniasis (CVL). observées chez les chiens du groupe malade que chez le groupe sous-clinique, alors qu'aucune différence n'a été notée entre les réponses IgG2 chez les chiens des deux groupes cliniques. En outre, nous avons trouvé des réponses IgG1 plus faibles chez les chiens du groupe sous-clinique présentant une HR positive que chez les chiens des groupes sous-cliniques ou malades avec HR négative. Aucune différence n'a été trouvée entre les réponses IgG2 de ces deux groupes cliniques. Ces résultats suggèrent fortement que la réponse IgG1, mais pas IgG2, est associée à une susceptibilité à la leishmaniose viscérale canine.
Introduction
American canine visceral leishmaniasis (CVL) is a parasitic zoonosis widely distributed in Latin America and caused by Leishmania (L.) infantum chagasi (= Leishmania chagasi Cunha & Chagas 1937), a protozoan of the order Kinetoplastida, family Trypanosomatidae, and genus Leishmania [15, 19, 27] . CVL and human American visceral leishmaniasis (AVL -a disease caused by the same Leishmania species) are naturally transmitted by L. (L.) i. chagasi-infected phlebotomine sand fly -Lutzomyia longipalpis (Psychodidae: Phlebotomine) -the most important vector in Brazil [14] . Taking into account the epidemiology of these diseases, it seems reasonable to assume that CVL is more prominent than AVL due to its higher prevalence, as well as the fact that both subclinical (= apparently healthy) and clinically sick dogs may act as sources of infection of the phlebotomine vector [17, 30] . Additionally, in light of the high prevalence of CVL in endemic AVL areas, the persistent skin parasitism found in the infected dogs, and the emergence of CVL earlier than AVL, there can be no doubt about the important role of dogs in the epidemiology of AVL. The estimated canine/human infection ratio was 4:1 in the Brazilian Amazon [29] .
With regards to the clinical features of canine L. (L.) i. chagasi-infection, there is a consensus that infected dogs can show a spectrum of clinical signs varying from subclinical to severe terminal illnesses that usually culminate in death. These clinical signs include lymphadenopathy, periorbital and nasal dermatitis, onychogryphosis, fever, apathy, diarrhea, intestinal hemorrhaging, loss of weight, splenomegaly, and hepatomegaly. Ulceration of the nose, ears, and tail are also frequently observed [12] . Additionally, there is some evidence from canine Leishmania (L.) infantum-infection in the Mediterranean region of Europe showing that subclinical infected dogs can convert to diseased animals following periods ranging from three months to seven years [20, 31] . In the Brazilian Amazon, a recent investigation that followed a dog cohort for two years reported a 35.6% rate of subclinical dogs that converted to diseased states [7] .
In contrast with the murine model of Leishmania (L.) major, no consistent associations have yet been described concerning IgG1 and IgG2 subclass ratios and disease resistance in canine infection -suggesting that those inconsistent results may partially reflect a low specificity of Leishmania-antigenic preparations and/or commercial antibodies. As such, a previous study carried out in Pará State in the Brazilian Amazon that examined IgG1-IgG4 responses in a cohort of 57 naturally infected dogs (seropositive for IgG) demonstrated that all IgG subclasses, detected by a panel of monoclonal antibodies, were higher in sick dogs than in healthy animals, suggesting that CVL is associated with the upregulation of all IgG subclasses, particularly IgG1, IgG3 and IgG4 [25] . Additionally, a new study used stored sera from the same dogs of the previous study and IgG1 and IgG2 responses to crude Leishmaniaantigens were specifically measured using commercial polyclonal antibodies, revealing that both IgG1 and IgG2 subclasses had higher titers in clinically sick dogs than in healthy dogs. This showed general upregulation of IgG in these infected animals [8] . A survey undertaken in São Paulo State (southeastern Brazil), however, identified the likely dominance of particular IgG subclasses in 120 sera from confirmed seropositive dogs as evaluated by ELISA, demonstrating a dominant IgG1 response in subclinical dogs. Diseased dogs showed a mixed pattern of IgG subclass productions [23] .
Studies of CVL immune responses to canine L. (L.) infantum-infections in the Mediterranean region showed definite similarities to the results of Brazilian research concerning the IgG1 and IgG2 canine immune responses to L. (L.) i. chagasi-infection. One of these European reports analyzed IgG subclass responses using ELISA, and concluded that dogs produced both IgG1 and IgG2 antibodies, with IgG2 being associated with subclinical infections and IgG1 with disease expression, suggesting that the differential responses indicated dichotomous immune responses [10] . In another study carried out in Lyon, France, IgG1 and IgG2 levels were examined in 14 dogs (six subclinical and eight sick) using ELISA. The assays detected both IgG1-and IgG2-specific antibodies in fourteen infected dogs -but the IgG2 subclass appeared to be predominant [3] . In Barcelona, Spain, IgG1 and IgG2 expressions were examined in 109 sera from 50 dogs using ELISA and were then compared to clinical conditions (subclinical or sick). IgG1 and IgG2 responses of clinical and subclinical infections were found to differ mainly in terms of subclass production values, with higher IgG2 production occurring especially in sick dogs [13] . Additionally, IgG1 and IgG2 responses were measured and compared in Trás-os-Montes and Alto Douro, Portugal, with the delayed-type hypersensitivity (DTH) response in three groups of dogs clinically and serologically characterized as: -subclinical and direct agglutination test (DAT)-seronegative; -subclinical and DAT-seropositive; -DAT-seropositive and sick. IgG2 was considered a marker of disease, as significantly higher levels of this subclass were recorded in sick dogs [6] .
Thus, regarding the inconsistent associations concerning resistance or susceptibility markers to CVL based on IgG1 and IgG2 responses, we decided to analyze these IgG subclass responses taking into account their relationships with the clinical statuses and DTH responses of infected dogs. This was the focus of the present study designed to amplify our understanding of the clinical-immunological parameters of canine infection. This approach was designed to address specific questions concerning parasite interactions with canine immune responses with the aim of contributing to new control strategies against the disease.
Materials and methods

Ethics approval
This work was undertaken in accordance with standard ethics criteria for scientific research using animals. The project was approved by the Ethics Committee for Animal Use in Research of the Evandro Chagas Institute, license No. 007/2012. The dog owners were informed of the objectives of the study and consented to, and signed, a free consent and understanding agreement.
Study area
Our study was undertaken in an endemic area for AVL in Vila Santana do Cafezal, located approximately 7 km from the administrative center of the municipality of Barcarena (01°30' S -48°37' W), Pará State, Brazil. This area was chosen because it demonstrates ecological and social economic conditions favorable to AVL transmission. These aspects were described in earlier studies that recorded 85% prevalence of the phlebotomine vector Lu. longipalpis in and around human habitations in this area [33] , as well as a canine infection prevalence of 43% (based on humoral responses by the indirect fluorescence antibody test [IFAT-IgG] and cellular responses by DTH) [29] .
Study design and the canine population examined
The study was designed as a cross-sectional examination of a population of 50 dogs showing positive serodiagnoses for CVL (IFAT-IgG) that had been randomly selected during an epidemiological survey which examined 316 dogs for CVL (July/August 2012) in the village Santana do Cafezal, municipality of Barcarena, Pará State, Brazil [7] . In addition to the IFAT-IgG, leishmanin skin tests (LST) were performed on the dogs, and eight of 50 also showed LST reactivity (= DTH positive).
After the selection of 50 dogs showing immunological diagnoses of infection (being 100% seropositive [IFATIgG] and 16% DTH positive), their serum samples were also ELISA (IgG) tested, which confirmed their serological reactivity and their inclusion in the present study. The serum samples were subsequently submitted to ELISA testing against the polyclonal antibodies IgG1 and IgG2, following previous research [16, 18, 22] , to better evaluate the responses of these subclasses to natural infections as well as to correlate the responses with the clinical states and cellular DTH responses of the dogs.
Clinical evaluations and the characteristics of infected dogs
As described above, all of the 316 dogs included in the research design that had been diagnosed for natural infection were clinically evaluated by a veterinarian, who recorded the clinical signs of each animal individually. After clinical inspection, the animals were classified into two groups: a subclinical group (SCG) -infected, but without clinical signs of illness (= apparently health); and diseased cinical group (DCG) -infected, and showing clinical signs of illness (= sick) [32] . Among the 22 clinically ill dogs, the most frequent clinical signs encountered were: thinning, cachexia, dermatitis, onychogryphosis, skin ulcers, hepatomegaly, splenomegaly, and lymphadenopathy.
As such, the dog population in the present study (n = 50) comprised 28 SCG (56%) and 22 DCG animals (44%). Of the 28 SCG dogs, 20 (71.4%) were males and eight (28.6%) were females; of the 22 DCG animals, 10 (45.5%) were males and 12 (54.5%) were females. In terms of their ages, of the 28 SCG animals, 26 (92.8%) were < 7 years, and two (7.2%) were ≥ 7 years; among the 22 DCG dogs, 20 (90.9%) were < 7 years, and two (9.1%) were ≥ 7 years.
Collection of tissue samples
Blood samples were taken from dogs in the study area with the consent of their owners, who also signed a free consent and understanding agreement. For the serological testing, the dogs were immobilized and a 3 mL blood sample was taken intravenously (cephalic vein). The samples were then stored, without anticoagulants, to obtain the serum samples; the material was subsequently kept at À20°C until use.
Immunological test procedures
In order to optimize the enzyme-linked immunosorbent assay (ELISA), we tested different soluble concentrations of promastigote-antigens of the same L. (L.) i. chagasi strain (MCAO/BR/2010/M27840/Barcarena, Pará) used for the LST and IFAT assays in previous epidemiologic surveys [7] , as well as different dilutions of control positive sera with low, moderate, and high titers, alkaline phosphatase conjugates, and cut-off levels. After checkerboard titrations, the best discriminative conditions between positive and negative controls for each isotype were defined, and the ELISA performed as follows: a suspension of stationary-phase promastigote was disrupted by freeze-thawing, then centrifuged at 10 000 g for 30 min at 4°C. To determine antigen concentrations, standardizations were performed by constructing a standard curve using different concentrations, which L.V.d.R. Lima et al.: Parasite 2017, 24, 37provided a final protein concentration of 400 mg/mL using the Bradford method [4] ; the samples were then stored at À20°C until use.
The microplates were coated with 10 mg/mL of the soluble IgG antigen in 0.1 M carbonate-bicarbonate buffer (pH 9.5), or with 20 mg/mL for IgG1 and IgG2, and held at 4°C overnight. After blocking the wells with 10% bovine albumin solution PBS with added 0.05% Tween (PBS-T), 100 mL of the diluted serum samples (at ratios of 1:400 to 1:6400 for IgG, and 1:200 to 1:3200 for both IgG1 and IgG2) were added to each well (two-fold dilutions) and incubated at 37°C for 2 hours. After washing with PBS-T, 100 mL of alkaline phosphatase-labeled secondary antibody solutions at dilutions of 1:2000 for IgG, and 1:500 for both IgG1 and IgG2 (Bethyl Laboratories, USA) in PBS-T were added to each well and the plates incubated at 37°C for 1 h. After further washing, 100 mL/well of 1.0 mg/mL pNPP (Sigma, USA) in 0.1 M pH 9.5 carbonate-bicarbonate buffer was added, and the samples incubated for 30 min at room temperature. The reactions were halted with 50 mL/well of 1 M NaOH, and absorbance was subsequently measured at 405 nm using an ELISA reader. The minimum detection level (cut-off) was set at the mean optical density obtained from the negative controls plus three standard deviations [16, 18, 22] .
The negative control (n = 5) and test (n = 50) serum samples were serially diluted (base 2), in duplicate. The results were expressed using the serological titration method for ELISA, that is, the inverse of the last dilution in which the sera demonstrated greater absorbance than the cut-off value, which were calculated for each of the negative sera control dilutions [9] . To interpret the results, the mean values of the absorbencies of the test samples (at each dilution level) were compared to the cut-off value until the final point could be determined (the first dilution in which the mean absorption was less than the cut-off point). The titer was considered the inverse of the last dilution before the final point. The cut-off of each solution was determined by the mean of the absorption of the negative serum controls plus three standard errors.
Data analysis
Log 10 transformations of the sera titer values obtained using ELISA were used in all analysis stages. We tested the null hypothesis that the differences of proportions observed between variables in the study were not significant using Fisher's exact test (a = 0.05). Thus, we evaluated possible discrepancies between proportions, which could either indicate selection bias or suggest associations between the variables. Additionally, two-way Analysis of Variance (ANOVA) (a = 0.05), followed by Turkey's multiple comparisons test (a = 0.05), were used to compare the mean values of the sera titer of the different groups; 95% confidence intervals of the differences between the mean sera titer values were also calculated. Furthermore, we evaluated possible correlations between the values of IgG, IgG1, and IgG2 using Pearson's linear correlation coefficient (r), a paired t test (a = 0.05) to evaluate the null hypothesis that r is not different from zero; the coefficient of determination (R 2 ) was used to evaluate how variables share their variability, and the 95% confidence interval of r. All data analyses were performed using GraphPad Prism version 6.00 for Mac (GraphPad Software, La Jolla, California USA, www.graphpad.com).
Results
Sample validation
In general, no evidence of discrepancies between the observed frequencies in the dataset was found (Figure 1) . In other words, no significant differences were found between frequencies of male and female dogs considering We also evaluated the degree of correlation between serological titers of IgG, IgG1, and IgG2 within the DCG and SCG groups, and no relevant correlation was found ( Figure 3) . However, the p value described in Table 1 suggests that, not by chance, there is a statistically positive correlation in the DCG group between the IgG and IgG1 values (p = 0.007). In addition, although the amplitude of the confidence interval of r coefficient (Table 1) indicates that this statistical correlation is not clinically significant, the determination coefficient (R 2 = 0.3107) indicates that IgG and IgG1 within the DCG group are well correlated, e.g., vary together in a similar fashion, differently from IgG and IgG1 (R 2 = 0.004475) and IgG and IgG2 (R 2 = 0.04619) in the SCG group, and also differently from IgG and IgG2 values (R 2 = 0.1204) in the DCG group. Finally, it is also worth noting (Figure 3) that IgG values were generally greater than IgG1 values within all groups, and that IgG2 values were generally larger than IgG and IgG1 values, corroborating the results presented in Figure 2 . ) and DCG (DTH (À) ) groups (p > 0.9999). However, when the confidence interval of means was also considered, there were verified statistical differences of IgG1 among the analyzed groups (p < 0.05) ( Figure 4A-B) .
We also evaluated the degree of correlation between serological titers of IgG, IgG1 and IgG2 within the SCG DTH (+) , SCG DTH (À) and DCG DTH (À) groups, and no relevant correlation was found ( Figure 5) . Nonetheless, the p value described in Table 2 suggests that, and not by chance, there is a statistically positive correlation between IgG and IgG2 values (p = 0.0069) in the SCG group. Although the amplitude of the confidence interval of the r coefficient ( Figure 4 .
Discussion
We investigated the likely roles of IgG1 and IgG2 responses as resistance or susceptibility markers of the outcome of CVL in the Brazilian Amazon. Unlike previous work carried out in this region [8, 25] or in other areas of Brazil [23] , or France [3] , and Spain [13] , the present work sought to correlate the expression of the IgG1 and IgG2 subclasses not only to the clinical conditions of infected dogs, but also to DTH, which has been recognized as a significant factor of protection against infection [2, 5, 24, 28] . Only the work of Cardoso et al. [6] , undertaken in Portugal, associated these IgG subclasses of canine infection with the clinical state and DTH. Although animal gender has been examined in terms of the clinical state of canine infection with totally negative results [28] , we re-examined this variable, testing for any correlation with the expression of the IgG1 and IgG2 subclasses as well as with DTH. Animal gender did not influence infection development with respect to the clinical state or immune responses, whether humoral (IgG1 and IgG2) or T-cell (DTH); similar results were observed during studies of canine infections in Europe [1, 20, 21] .
The evaluation of the IgG, and IgG1 and IgG2 subclasses suggested that the IgG1, but not the IgG2, represents a determinant factor and/or marker of canine susceptibility to disease evolution. When the levels of the IgG1 and IgG2 were compared based on the clinical state of the infection, both SCG and visibly DCG dogs showed significantly greater IgG2 than IgG1 levels. When this comparison considered these clinically different groups of dogs, however, it could be seen that the IgG1 response of the DCG was significantly greater than that of the SCG, while the IgG2 response of dogs in the DCG was similar to that of the SCG. This indicates that the IgG1 response of the SCG was significantly smaller than that of the visibly DCG, as well as the IgG2 response of the dogs in both the SCG and DCG groups. Thus, while the levels of IgG2 were similar among dogs from the two clinical groups, their IgG1 levels differed, being significantly greater in DCG dogs. Additionally, examinations of their IgG levels (and the IgG1 and IgG2 subclasses) indicated that only IgG1 levels were significantly inferior to IgG in both DCG and SCG dogs -reinforcing the idea that IgG1 expression is consistently less than IgG and IgG2. Likewise, comparisons of the levels of IgG and its IgG1 and IgG2 subclasses with the clinical states of these animals showed that there were no significant correlations between the values of these immunoglobulins in SCG and DCG dogs. This indicates that the IgG1 and IgG2 responses represent independent and unequivocal immune-biological events and that IgG1 exercises unappropriate immune response that facilitates not only infection progression, but also its evolution from asymptomatic to symptomatic. An increased level of IgG1 is potentially a marker of this deleterious immune response.
It can therefore be seen that our results diverge from two earlier studies in the same geographic region that suggested that all of the IgG subclasses showed higher levels in DCG than SCG dogs [8, 25] , but only the IgG1 subclass showed higher levels in the former, while the IgG2 subclass had similar levels in both groups. This also contrasted with reports from São Paulo and Minas Gerais States (southeastern Brazil) [23, 26] that suggested that IgG2 is responsible for infection progression.
These discrepancies become more evident when the results are compared with European studies. A number of studies in France, Spain, and Portugal, for example, reported the action of IgG2 with the development of symptomatic infections -therefore assuming that IgG2 plays a stronger immunopathogenic role than IgG1 [3, 6, 13, 31] . Deplazes et al. [10] (Figure 4, bottom) , the apparent absence of statistical differences could be explained by the fact that this analysis did not consider the variability of IgG1 levels in the samples, but only the differences between mean IgG1 levels. As the mean IgG1 values of the eight SCG (DTH (+) ) dogs were exactly equal, the mean IgG1 value of this group generated a mean, without sample variability. As such, the solution for this inconsistency was to analyze the difference between the 95% confidence intervals of the means, an analysis that centers on the variability of the IgG1 values in the samples of the SCG (DTH (À) ) and SCG (DTH (+) ) groups, allowing us to evaluate the true differences between their IgG1 levels (Figure 4, top) . It can then be seen that there was a strong tendency for the IgG1 levels of SCG (DTH (À) ) dogs to be greater than those of SCG (DTH (+) ) animals, suggesting that the IgG1 levels of SCG (DTH (À) ) dogs were greater than those of SCG (DTH (+) ) animals. IgG1 levels also progressively increased from SCG (DTH (+) ) dogs, to SCG (DTH (À) ), and finally to DCG (DTH ) and DCG dogs (DTH (À) )], IgG1 expression would be less controlled (more evident).
Confirming these observations is the fact that there were no strong correlations between IgG levels (and their IgG1 and IgG2 subclasses) and the clinical states of the dogs and their DTH expressions in either of the groups analyzed. This was the case despite the fact that these SCG DTH 
/DTH
(À) dogs were lower than those of DCG DTH (À) dogs (as well as their IgG and IgG2 levels). As noted earlier, the results of Cardoso et al. [7] were similar to those observed in the present work reinforcing our proposal that the DTH (+) of the infected dogs must be controlling the expression of the IgG1 and IgG2 subclasses, in spite of the fact that IgG2 expression in sick dogs (DCG: DTH (À) ) and in apparently healthy animals (SCG: DTH (+) /DTH (À) ) are similar to (although higher than) IgG1 expression. Santos et al. [11] also demonstrated for Brazil that dogs with positive splenic cultures and DTH (À) had higher levels of IgG and IgG2 than dogs with negative splenic cultures and DTH (+) . 
Funding
